|
Market Closed -
Nasdaq
16:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 1.960 USD | -0.51% |
|
-2.00% | -45.25% |
| 08-18 | Top Premarket Decliners | MT |
| 05-19 | Natural Alternatives International, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year 2026 | CI |
| Market Cap | 15M 13M 12.28M 11.15M 20.9M 1.44B 21.03M 147M 56.67M 730M 56.34M 55.09M 2.33B | P/E 2024 |
-4.89x | P/E 2025 | -1.44x |
|---|---|---|---|---|---|
| Enterprise Value | 61.7M 53.47M 50.54M 45.88M 85.99M 5.92B 86.51M 603M 233M 3B 232M 227M 9.57B | EV / Sales 2024 |
0.75x | EV / Sales 2025 | 0.52x |
| Free-Float |
50.96% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NAII | Delayed | |
CBOE
| NAII | Real-time | |
Deutsche Boerse AG
| NA2 | Delayed | |
Börse Stuttgart
| NA2 | Delayed | |
Boerse Muenchen
| NA2 | Real-time |
| 1 day | -0.51% | ||
| 1 week | -2.00% | ||
| Current month | -7.11% | ||
| 1 month | -3.92% | ||
| 3 months | -21.60% | ||
| 6 months | -26.04% | ||
| Current year | -45.25% |
| 1 week | 1.9 | 2.24 | |
| 1 month | 1.9 | 2.42 | |
| Current year | 1.9 | 4.96 | |
| 1 year | 1.9 | 4.96 | |
| 3 years | 1.9 | 7.37 | |
| 5 years | 1.9 | 15.5 | |
| 10 years | 0 | 19.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CEO | Chief Executive Officer | 72 | 1985-12-31 |
Kenneth Wolf
DFI | Director of Finance/CFO | 65 | 2026-05-14 |
Nancy Steely
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark LeDoux
CHM | Chairman | 72 | 2000-12-31 |
Alan Dunn
BRD | Director/Board Member | 71 | 2003-12-31 |
Laura Matherly
BRD | Director/Board Member | 62 | 2019-12-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/6/26 | Free | Director | 8,000 | 0.1295% | ||
| 3/6/26 | Tax | Chief Financial Officer | 20,151 | 0.3262% | ||
| 3/6/26 | Free | Director | 8,000 | 0.1295% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.51% | -2.00% | -37.46% | -70.53% | 12.3M | ||
| +0.15% | +1.21% | +48.79% | +97.65% | 1,014B | ||
| +0.03% | +0.07% | +51.47% | +65.55% | 644B | ||
| -0.20% | +4.62% | +21.39% | +72.57% | 464B | ||
| -1.41% | +3.73% | +37.63% | +38.94% | 354B | ||
| +0.46% | +2.50% | +19.01% | +24.91% | 265B | ||
| +0.92% | +4.42% | +7.74% | +14.45% | 253B | ||
| +0.19% | -3.81% | +37.81% | +44.35% | 203B | ||
| +0.16% | -4.45% | -25.97% | -57.94% | 186B | ||
| +0.94% | +1.39% | +33.21% | +95.16% | 183B | ||
| Average | +0.17% | +0.66% | +19.36% | +32.51% | 356.68B | |
| Weighted average by Cap. | +0.16% | +1.41% | +34.15% | +60.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 114M 98.62M 93.21M 84.62M 159M 10.92B 160M 1.11B 430M 5.54B 427M 418M 17.65B | 130M 113M 106M 96.56M 181M 12.46B 182M 1.27B 491M 6.32B 488M 477M 20.14B |
| Net income | -7.22M -6.25M -5.91M -5.37M -10.06M -692M -10.12M -70.57M -27.27M -351M -27.11M -26.51M -1.12B | -13.58M -11.76M -11.12M -10.09M -18.92M -1.3B -19.03M -133M -51.29M -661M -50.99M -49.86M -2.11B |
| Net Debt | 48.31M 41.87M 39.57M 35.92M 67.33M 4.63B 67.73M 472M 183M 2.35B 181M 177M 7.49B | 46.7M 40.47M 38.26M 34.73M 65.09M 4.48B 65.48M 457M 176M 2.27B 175M 172M 7.24B |
Employees
293
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-16 | US$1.960 | -0.51% | 14,741 |
| 26-09-15 | US$1.970 | +0.51% | 1,647 |
| 26-09-14 | US$1.960 | 0.00% | 35,846 |
| 26-09-11 | US$1.960 | -2.97% | 8,386 |
| 26-09-10 | US$2.020 | +1.00% | 4,632 |
- Stock Market
- Stocks
- NAII Stock
Select your edition
All financial news and data tailored to specific country editions

















